The Gut–Liver Axis in Metabolic Dysfunction–Associated Steatotic Liver Disease and Associated Hepatocellular Carcinoma: Pathogenesis and Therapeutic Interventions
The Gut–Liver Axis in Metabolic Dysfunction–Associated Steatotic Liver Disease and Associated Hepatocellular Carcinoma: Pathogenesis and Therapeutic Interventions. // The American Journal of Pathology. – URL: https://www.sciencedirect.com/science/article/pii/S0002944026002828?dgcid=rss_sd_all
The Gut–Liver Axis in Metabolic Dysfunction–Associated Steatotic Liver Disease and Associated Hepatocellular Carcinoma: Pathogenesis and Therapeutic Interventions. The American Journal of Pathology. https://www.sciencedirect.com/science/article/pii/S0002944026002828?dgcid=rss_sd_all
“The Gut–Liver Axis in Metabolic Dysfunction–Associated Steatotic Liver Disease and Associated Hepatocellular Carcinoma: Pathogenesis and Therapeutic Interventions.” The American Journal of Pathology.
@article{article95285,
title = {The Gut–Liver Axis in Metabolic Dysfunction–Associated Steatotic Liver Disease and Associated Hepatocellular Carcinoma: Pathogenesis and Therapeutic Interventions},
journal = {The American Journal of Pathology},
url = {https://www.sciencedirect.com/science/article/pii/S0002944026002828?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....